Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals.
Fred C Tenover, Isabella Tickler, Eliana S Armstrong, Aya Kubo, Sara Lopez, David H Persing, George H Miller
Index: Int. J. Antimicrob. Agents 38(4) , 352-4, (2011)
Full Text: HTML
Abstract
The activity of ACHN-490 was evaluated against 493 meticillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2009-2010 from 23 US hospitals. The MIC(50) and MIC(90) values (minimal inhibitory concentrations for 50% and 90% of the organisms, respectively) for ACHN-490 were 1 and 2 μg/mL compared with 8 and 32 μg/mL for amikacin, 0.5 and 1 μg/mL for gentamicin and 2 and >16 μg/mL for tobramycin. The gene encoding the aminoglycoside-modifying enzyme APH(2″)-Ia/AAC(6')-Ie was present in 12% of the subset of 84 isolates examined by polymerase chain reaction (PCR), whilst the gene encoding ANT(4')-Ia was present in 89% of isolates. ACHN-490 activity was not affected by either enzyme.Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Related Compounds
Related Articles:
2015-01-01
[J. Pharm. Biomed. Anal. 111 , 126-30, (2015)]
2010-03-28
[Chem. Commun. (Camb.) 46(12) , 2013-5, (2010)]
2011-12-01
[Antimicrob. Agents Chemother. 55(12) , 5874-80, (2011)]
2010-10-01
[J. Antimicrob. Chemother. 65(10) , 2123-7, (2010)]
2010-05-01
[Antimicrob. Agents Chemother. 54(5) , 2258-61, (2010)]